EGFR and laryngotracheoesophageal cleft: <i>In vitro</i> experiments confirmed the pro-resistance and pro-metastatic functions of ACTN1 in osimertinib-resistant LC cells.<h4>Conclusion</h4>ACTN1 was discovered to induce malignant progression and formation of EGFR-TKI resistance.